CF Industries Holdings Inc(CF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CF CF Industries Holdings Inc

Not Yet Opened 05-17 16:00:00 EDT

76.22

-1.10

-1.42%

盘后76.22

+0.000.00%

19:32 EDT

High77.40	Low75.74	Vol1.29M
Open77.28	D1 Closing77.32	Amplitude2.15%
Mkt Cap13.93B	Tradable Cap13.82B	Total Shares182.78M
T/O97.99M	T/O Rate0.71%	Tradable Shares181.36M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CF","market":"US","secType":"STK","nameCN":"CF Industries Holdings Inc","latestPrice":76.22,"timestamp":1715976000000,"preClose":77.32,"halted":0,"volume":1285545,"hourTrading":{"tag":"盘后","latestPrice":76.22,"preClose":76.22,"latestTime":"19:32 EDT","volume":66046,"amount":5034028.35,"timestamp":1715988725030},"delay":0,"floatShares":181362248,"shares":182782174,"eps":6.042713,"marketStatus":"Not Yet Opened","change":-1.1,"latestTime":"05-17 16:00:00 EDT","open":77.28,"high":77.4,"low":75.74,"amount":97986713.28858,"amplitude":0.021469,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.042713,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1123732800000,"exchange":"NYSE","adjPreClose":77.32,"dividendRate":0.022304,"preHourTrading":{"tag":"盘前","latestPrice":76.89,"preClose":77.32,"latestTime":"09:16 EDT","volume":207,"amount":15977.95119,"timestamp":1715951797292},"postHourTrading":{"tag":"盘后","latestPrice":76.22,"preClose":76.22,"latestTime":"19:32 EDT","volume":66046,"amount":5034028.35,"timestamp":1715988725030},"volumeRatio":0.7331148265199245},"requestUrl":"/m/hq/s/CF","defaultTab":"news","newsList":[{"id":"2436926962","title":"CF Industries Holdings Inc. Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2436926962","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2436926962?lang=en_us&edition=fundamental","pubTime":"2024-05-18 05:17","pubTimestamp":1715980620,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of CF Industries Holdings Inc.  slipped 1.42% to $76.22 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.12% to 5,303.27 and the Dow Jones Industrial Average  rising 0.34% to 40,003.59.The stock's fall snapped a four-day winning streak.CF Industries Holdings Inc. closed $11.68 below its 52-week high , which the company achieved on September 26th.Trading volume  remained 1.3 million below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 17, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2435711698","title":"CF Industries Holdings Inc. Stock Rises Wednesday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2435711698","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2435711698?lang=en_us&edition=fundamental","pubTime":"2024-05-16 05:19","pubTimestamp":1715807940,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of CF Industries Holdings Inc.  inched 0.59% higher to $74.82 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.17% to 5,308.15 and the Dow Jones Industrial Average  rising 0.88% to 39,908.00.This was the stock's third consecutive day of gains.CF Industries Holdings Inc. closed $13.08 short of its 52-week high , which the company reached on September 26th.Trading volume  remained 1.0 million below its 50-day average volume of 2.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 15, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2435545730","title":"Houlihan Lokey: Leader Of The Restructuring League Expected To Grow More","url":"https://stock-news.laohu8.com/highlight/detail?id=2435545730","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435545730?lang=en_us&edition=fundamental","pubTime":"2024-05-15 00:30","pubTimestamp":1715704231,"startTime":"0","endTime":"0","summary":"Houlihan Lokey, a boutique investment bank, has seen higher-than-expected earnings in the restructuring space, with a record number of engagements.The bank's Corporate Finance segment is the largest, ","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1186947981/image_1186947981.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1186947981/image_1186947981.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4693108-houlihan-lokey-leader-restructuring-expected-to-grow-more","is_publish_highlight":false,"gpt_icon":0},{"id":"2435548887","title":"Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2435548887","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2435548887?lang=en_us&edition=fundamental","pubTime":"2024-05-14 21:45","pubTimestamp":1715694308,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.Why This 1 Growth Stock Should Be On Your Watchlist. For growth investors, a company's financial strength, overall health, and future outlook take precedence, so they'll want to zero in on the Growth Style Score. This Score examines things like projected and historical earnings, sales, and cash flow to find stocks that will generate sustainable growth over time.Boston, MA-based Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company’s main area of focus is cystic fibrosis .On a historic basis, Vertex Pharmaceuticals has generated cash flow g","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kz0ozt3ejWMPXKci2JxOBw--~B/aD03NTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kz0ozt3ejWMPXKci2JxOBw--~B/aD03NTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-vertex-pharmaceuticals-vrtx-134508634.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435642583","title":"CF Industries Holdings Inc. Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2435642583","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2435642583?lang=en_us&edition=fundamental","pubTime":"2024-05-14 05:18","pubTimestamp":1715635080,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of CF Industries Holdings Inc.  inched 0.42% higher to $74.26 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.02% to 5,221.42 and Dow Jones Industrial Average  falling 0.21% to 39,431.51.CF Industries Holdings Inc. closed $13.64 short of its 52-week high , which the company reached on September 26th.Trading volume  remained 848,111 below its 50-day average volume of 2.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 13, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2435876371","title":"Intrepid Potash (IPI) Q1 Earnings Lag, Sales Beat Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2435876371","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2435876371?lang=en_us&edition=fundamental","pubTime":"2024-05-13 20:44","pubTimestamp":1715604240,"startTime":"0","endTime":"0","summary":"Intrepid Potash, Inc. IPI recorded a loss of 24 cents per share in first-quarter 2024. The company had reported earnings of 35 cents per share in the year-ago quarter.Barring one-time items, the adjusted loss in the reported quarter was 14 cents per share. The Zacks Consensus Estimate was earnings of 4 cents.The company registered revenues of $79.3 million for the quarter, down around 9% year over year. Revenues beat the Zacks Consensus Estimate of $62.9 million.The company had roughly $46.5 million in cash and cash equivalents, no outstanding borrowings, and $150 million available to borrow under its revolving credit facility at the end of the quarter.Cash flow from operations was $41.5 million in the reported quarter.The company still sees capital expenditure of between $40 million and $50 million for 2024. IPI's capital spending remains focused on potash assets to allow it to meet its objective of maximizing brine availability and underground brine residence time, which are expected","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ShfhwtDyA2WzDBKdAL7M8Q--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6f2cab89bf2cbad1966358e04258e202","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ShfhwtDyA2WzDBKdAL7M8Q--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6f2cab89bf2cbad1966358e04258e202"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intrepid-potash-ipi-q1-earnings-124400160.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435634554","title":"Cf Industries Holdings (CF) Receives a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2435634554","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435634554?lang=en_us&edition=fundamental","pubTime":"2024-05-13 15:46","pubTimestamp":1715586416,"startTime":"0","endTime":"0","summary":"In a report released today, Benjamin Theurer from Barclays maintained a Hold rating on Cf Industries Holdings (CF – Research Report), with a price ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cf-industries-holdings-cf-receives-a-hold-from-barclays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cf-industries-holdings-cf-receives-a-hold-from-barclays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435212273","title":"Recce Pharmaceuticals Reports Positive Preclinical Data of RECCE® 327 in Lung Infection Pilot Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2435212273","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2435212273?lang=en_us&edition=fundamental","pubTime":"2024-05-13 12:00","pubTimestamp":1715572800,"startTime":"0","endTime":"0","summary":"RECCE 327 (R327) demonstrated >99% log reduction (>2.5 log reduction) in Mycobacterium abscessus lung infections using a nebulizer delivery methodR327 is being evaluated for potential use to treat ven","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/13/2880360/0/en/Recce-Pharmaceuticals-Reports-Positive-Preclinical-Data-of-RECCE-327-in-Lung-Infection-Pilot-Study.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435352610","title":"Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2435352610","media":"Motley Fool","top":-1,"share":"https://ttm.financial/m/news/2435352610?lang=en_us&edition=fundamental","pubTime":"2024-05-13 02:47","pubTimestamp":1715539620,"startTime":"0","endTime":"0","summary":"The biotech's shares dropped following its latest quarterly update, but that shouldn't matter to long-term investors.","market":"us","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F776494%2Fpatient-taking-medicine.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F776494%2Fpatient-taking-medicine.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/05/12/vertex-pharmaceuticals-is-racing-towards-new-block/","is_publish_highlight":false,"gpt_icon":1},{"id":"2434325443","title":"CVR Partners: The Chances Of A Near-Term Sale Are Increasing","url":"https://stock-news.laohu8.com/highlight/detail?id=2434325443","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2434325443?lang=en_us&edition=fundamental","pubTime":"2024-05-12 20:32","pubTimestamp":1715517165,"startTime":"0","endTime":"0","summary":"CVR Partners is an undervalued stock with significant opportunity due to its unique competitive advantages and lack of professional analyst coverage.CVRP's competitive advantages include its proximity to the US corn belt, production of low-carbon ammonia, use of pet coke as feedstock, and focus on nitrogen fertilizer for agricultural applications.The North American fertilizer market has high-demand and limited supply, creating a potential premium for existing plants like CVRP. A sale of CVRP is highly likely, offering significant upside potential.   CactuSoup The Opportunity In a market that seems to be chasing the next big new shiny object, sometimes it makes sense to look in more overlooked corners that may be hiding significant opportunity. Yes, AI and Ozempic have huge potential, but these facts are well known. Where does the Alpha come from?When it comes to CVR Partners , the answer is clear. This stock is very thinly traded, has a less than $900m market cap, is a variable-distrib","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155415266/image_155415266.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155415266/image_155415266.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4692551-cvr-partners-the-chances-of-a-near-term-sale-are-increasing","is_publish_highlight":false,"gpt_icon":0},{"id":"2434894087","title":"CF Industries Holdings Inc. Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2434894087","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2434894087?lang=en_us&edition=fundamental","pubTime":"2024-05-11 05:18","pubTimestamp":1715375880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of CF Industries Holdings Inc.  shed 0.46% to $73.95 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.16% to 5,222.68 and the Dow Jones Industrial Average  rising 0.32% to 39,512.84.CF Industries Holdings Inc. closed $13.95 below its 52-week high , which the company reached on September 26th.Trading volume  remained 1.5 million below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 10, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2434047363","title":"4DMT Reports First Quarter 2024 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2434047363","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2434047363?lang=en_us&edition=fundamental","pubTime":"2024-05-10 04:05","pubTimestamp":1715285100,"startTime":"0","endTime":"0","summary":"Announced positive interim data from PRISM Phase 2 Dose Expansion cohort evaluating 4D-150 in wet AMD patients with severe disease activity and high treatment burden enabling advancement into Phase 3 expected by Q1 2025. Interim 24-week landmark analysis from PRISM Phase 2 Population Extension cohort evaluating 4D-150 in broader wet AMD population expected to be presented at the American Society of Retina Specialists  Annual Scientific Meeting on July 17-20, 2024. Interim clinical data from Phase 1/2 AEROW clinical trial expected to be presented at the European Cystic Fibrosis Society  Conference on June 5-8, 2024. Announced positive interim data for 4D-310 in Fabry disease cardiomyopathy, demonstrating durable responses on cardiac endpoints and promising cardiac biopsy results. Completed upsized public follow-on offering with total gross proceeds of $337 million; $589 million in cash and equivalents as of March 31, 2024 expected to fund operations into H1 2027. EMERYVILLE, Calif., May","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_dIhMI1e0EGfp7ki87crfg--~B/aD01NjA7dz0xOTc5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/6822d10ab37bc11df0216f4bd39730bf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_dIhMI1e0EGfp7ki87crfg--~B/aD01NjA7dz0xOTc5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/6822d10ab37bc11df0216f4bd39730bf"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4dmt-reports-first-quarter-2024-200500608.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434058518","title":"Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight","url":"https://stock-news.laohu8.com/highlight/detail?id=2434058518","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2434058518?lang=en_us&edition=fundamental","pubTime":"2024-05-09 13:04","pubTimestamp":1715231091,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc  showcases robust revenue growth and solid operational performance in its latest 10-Q filing.Strategic acquisitions and pipeline advancements position VRTX for potential market expansion and diversification.VRTX's commitment to innovation and R&D investment underscores its competitive edge in the biotechnology sector.Financial prudence and a strong balance sheet provide VRTX with the flexibility to navigate market uncertainties.Dependence on Core CF Franchise: Despite Vertex Pharmaceuticals Inc 's success in the CF market, its heavy reliance on this core franchise could pose risks. The 10-Q filing reveals that a significant portion of the company's revenue is generated from its CF treatments. While this specialization has allowed Vertex to excel, it also exposes the company to potential vulnerabilities should new competitors or therapies emerge. Diversifying its","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Ty.khDy_bkMLJTtIlmZGDQ--~B/aD03ODQ7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/e1a02e10c4173519d481acd991ac00a8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Ty.khDy_bkMLJTtIlmZGDQ--~B/aD03ODQ7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/e1a02e10c4173519d481acd991ac00a8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/decoding-vertex-pharmaceuticals-inc-vrtx-050451383.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434093665","title":"Royalty Pharma Reports First Quarter 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2434093665","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2434093665?lang=en_us&edition=fundamental","pubTime":"2024-05-09 11:00","pubTimestamp":1715223600,"startTime":"0","endTime":"0","summary":"Royalty Receipts growth of 14% driving Portfolio Receipts of $717 millionNet cash provided by operating activities of $665 millionFull year 2024 guidance confirmed: Portfolio Receipts expected to be $","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/09/2878619/0/en/Royalty-Pharma-Reports-First-Quarter-2024-Results.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434270454","title":"Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2434270454","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2434270454?lang=en_us&edition=fundamental","pubTime":"2024-05-09 04:01","pubTimestamp":1715198460,"startTime":"0","endTime":"0","summary":"Commercial manufacture of Kostaive on track for delivery of initial 4 million doses in Q3. Kostaive European Marketing Authorization Application approval decision expected Q3. Multiple Kostaive Phase 3 trials further demonstrate breadth and durability of STARR vaccine platform. ARCT-2138  Phase 1 topline immunogenicity and safety data, anticipated in Q3. ARCT-810  Phase 2 and ARCT-032  Phase 1b interim data and update to be provided on July 1st. JP Morgan engaged to monetize investment in ARCALIS JV in Japan. \"Arcturus continues to make encouraging progress in both our vaccine and therapeutics pipeline,\" said Joseph Payne, President & CEO of Arcturus. \"In collaboration with our global vaccine partner CSL and their partner Meiji Seika Pharma, we are excited to begin the commercialization of Kostaive this year.\". In March, Meiji Seika Pharma announced plans to supply Japan with 4 million doses of Kostaive for fall/winter season of 2024. To support this effort, Arcturus along with CDMO pa","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/m4ZsFqPVJIDHebJLIKXaWA--~B/aD0xMzIwO3c9MzYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/71f157a3f59288dfdea5fddf09a75e7a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/m4ZsFqPVJIDHebJLIKXaWA--~B/aD0xMzIwO3c9MzYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/71f157a3f59288dfdea5fddf09a75e7a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcturus-therapeutics-announces-first-quarter-200100200.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433726688","title":"While institutions own 25% of CF Bankshares Inc. (NASDAQ:CFBK), retail investors are its largest shareholders with 53% ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2433726688","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2433726688?lang=en_us&edition=fundamental","pubTime":"2024-05-08 20:58","pubTimestamp":1715173097,"startTime":"0","endTime":"0","summary":"The considerable ownership by retail investors in CF Bankshares indicates that they collectively have a greater say in management and business strategy. A total of 25 investors have a majority stake in the company with 46% ownership. A look at the shareholders of CF Bankshares Inc.  can tell us which group is most powerful. With 53% stake, retail investors possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises .Institutions, on the other hand, account for 25% of the company's stockholders. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones.Let's delve deeper into each type of owner of CF Bankshares, beginning with the chart below.The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects indi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XG3pUQ0O5AcnUd1ecjAVaw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/c355483febd8e77cc0daa4c43dbcf2ca","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XG3pUQ0O5AcnUd1ecjAVaw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/c355483febd8e77cc0daa4c43dbcf2ca"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/while-institutions-own-25-cf-125817146.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433748953","title":"5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=2433748953","media":"Motley Fool","top":-1,"share":"https://ttm.financial/m/news/2433748953?lang=en_us&edition=fundamental","pubTime":"2024-05-08 17:43","pubTimestamp":1715161380,"startTime":"0","endTime":"0","summary":"New drugs in development and a lack of significant patent cliffs ahead make this a great pharma stock to buy now and hold over the long run.","market":"fut","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F776190%2Finvestment-advisor-with-client-getty.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F776190%2Finvestment-advisor-with-client-getty.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/05/08/5-reasons-vertex-pharmaceuticals-is-a-screaming-bu/","is_publish_highlight":false,"gpt_icon":0},{"id":"2433071745","title":"Buy Rating for Vertex Pharmaceuticals Amid Strong CF Growth and Strategic Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2433071745","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2433071745?lang=en_us&edition=fundamental","pubTime":"2024-05-08 17:16","pubTimestamp":1715159761,"startTime":"0","endTime":"0","summary":"Analyst Mohit Bansal from Wells Fargo maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) and keeping the price target at $5...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-for-vertex-pharmaceuticals-amid-strong-cf-growth-and-strategic-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-for-vertex-pharmaceuticals-amid-strong-cf-growth-and-strategic-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2433996766","title":"2 ASX passive income shares poised to pay a 9% yield","url":"https://stock-news.laohu8.com/highlight/detail?id=2433996766","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2433996766?lang=en_us&edition=fundamental","pubTime":"2024-05-08 09:43","pubTimestamp":1715132639,"startTime":"0","endTime":"0","summary":"As inflation drives the cost of living higher, many are turning to passive income shares for returns. Thankfully, as an Australian investor, you're in the right place. There are plenty of ASX shares across all sectors paying chunky dividends to their shareholders, year after year. As we've noted before, dividends hedge against inflation, offer tax advantages (thank you, franking credits!) and provide a second source of investment return. Here are two passive income shares that experts think are fundamentally sound and poised to carry dividend yields of 9%. Incitec Pivot Ltd  First on the list of passive income shares is fertiliser and chemicals company Incitec Pivot. The company recently returned a mammoth $500 million of cash to its shareholders following the sale of its ammonia manufacturing plant toCF Industries Holdings Inc in 2023. In response, shareholders received two returns – one a 15.57 cents per share equal capital reduction, followed by an unfranked special dividend of 10.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/08/2-asx-passive-income-shares-poised-to-pay-a-9-yield/","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cfindustries.com","stockEarnings":[{"period":"1week","weight":0.0307},{"period":"1month","weight":-0.0203},{"period":"3month","weight":-0.019},{"period":"6month","weight":-0.016},{"period":"1year","weight":0.1599},{"period":"ytd","weight":-0.0413}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CF Industries Holdings, Inc. manufactures and sells hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities worldwide. Its principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. The company also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products; and compound fertilizer products with nitrogen, phosphorus, and potassium. It primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Deerfield, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.473684,"avgChangeRate":0.021263},{"month":2,"riseRate":0.736842,"avgChangeRate":0.070215},{"month":3,"riseRate":0.263158,"avgChangeRate":-0.042154},{"month":4,"riseRate":0.631579,"avgChangeRate":0.018049},{"month":5,"riseRate":0.526316,"avgChangeRate":-0.049962},{"month":6,"riseRate":0.444444,"avgChangeRate":0.011204},{"month":7,"riseRate":0.833333,"avgChangeRate":0.065847},{"month":8,"riseRate":0.555556,"avgChangeRate":0.033261},{"month":9,"riseRate":0.631579,"avgChangeRate":-0.000052},{"month":10,"riseRate":0.473684,"avgChangeRate":0.018251},{"month":11,"riseRate":0.631579,"avgChangeRate":0.023779},{"month":12,"riseRate":0.736842,"avgChangeRate":0.038865}],"exchange":"NYSE","name":"CF Industries Holdings Inc","nameEN":"CF Industries Holdings Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CF Industries Holdings Inc(CF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CF Industries Holdings Inc(CF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CF Industries Holdings Inc,CF,CF Industries Holdings Inc股票,CF Industries Holdings Inc股票老虎,CF Industries Holdings Inc股票老虎国际,CF Industries Holdings Inc行情,CF Industries Holdings Inc股票行情,CF Industries Holdings Inc股价,CF Industries Holdings Inc股市,CF Industries Holdings Inc股票价格,CF Industries Holdings Inc股票交易,CF Industries Holdings Inc股票购买,CF Industries Holdings Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CF Industries Holdings Inc(CF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CF Industries Holdings Inc(CF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction